Altos Labs

/
Institutes of Science

Steve Horvath, PhD

Principal Investigator

Principal Investigator

Steve Horvath, PhD

"I joined Altos for its unique collaborative research environment that is highly conducive for the next phase of my research, which is the use of epigenetic clocks to identify novel anti-aging interventions."

Dr. Steve Horvath is a Principal Investigator at the Altos Labs Cambridge Institute of Science.

Prior to joining Altos, Steve was a Professor of Human Genetics and Biostatistics at the University of California, Los Angeles. His research lies at the intersection of several fields including biogerontology, anti-aging clinical trials, epigenetic biomarkers of aging, epidemiology, systems biology, and comparative biology. Steve and his UCLA colleagues published the first epigenetic clock for saliva in 2011, the first pan-tissue clock (2013), and the first pan mammalian clock (2021). He is also known for developing weighted correlation network analysis (WGCNA), a widely used data mining method used in genomic applications. The recipient of several awards, Steve has been on Clarivate’s annual list of the world’s most influential scientific researchers every year since 2018.

Prior to joining Altos, Steve was a Professor of Human Genetics and Biostatistics at the University of California, Los Angeles. His research lies at the intersection of several fields including biogerontology, anti-aging clinical trials, epigenetic biomarkers of aging, epidemiology, systems biology, and comparative biology. Steve and his UCLA colleagues published the first epigenetic clock for saliva in 2011, the first pan-tissue clock (2013), and the first pan mammalian clock (2021). He is also known for developing weighted correlation network analysis (WGCNA), a widely used data mining method used in genomic applications. The recipient of several awards, Steve has been on Clarivate’s annual list of the world’s most influential scientific researchers every year since 2018.

Steve Horvath, PhD

"I joined Altos for its unique collaborative research environment that is highly conducive for the next phase of my research, which is the use of epigenetic clocks to identify novel anti-aging interventions."